16-Feb-2012 By Nick Taylor
Hospira hopes to ramp up output at its Rocky Mount facility in the second half of 2012 but warned it is “very difficult” to predict the remediation timeline.
13-Feb-2012 By Nick Taylor
Earnings at Catalent jumped in the second quarter as rising demand for its oral technologies offset weakness in sterile injectables.
09-Feb-2012 By Nick Taylor
GSK is bringing outsourced work back in-house and placing manufacturing at existing sites in a bid to boost efficiency.
08-Feb-2012 By Nick Taylor
United Drug has inked a four-year, €30m packaging services deal as it continues to grow the division, particularly in the US.
01-Feb-2012 By Nick Taylor
Pfizer is recalling 28 lots of contraceptives after a blister packaging error raised the risk of unintended pregnancy.
26-Jan-2012 By Natalie Morrison
Outsourcing-Pharma presents a round-up of the latest headlines within the world of contract manufacturing. Catalent and Patheon have each launched oral dosage partnership news, whilst Frontage and AMPAC have received regulatory go-aheads.
25-Jan-2012 By Nick Taylor
Lonza has fired its CEO after a halving of net income prompted the board to find another leader for “the challenging years ahead”.
25-Jan-2012 By Nick Taylor
A patent loss-fuelled surge in big pharma outsourcing will push the European CMO market through the $20bn barrier by 2018, analysis claims.
17-Jan-2012 By Nick Taylor
J&J has enough Doxil to meet the needs of patients on its waiting list but warned CMO Ben Venue is unlikely to resume supply until late 2012.
12-Jan-2012 By Nick Taylor
Outsourcing to Indian CRAMS and bulk drug businesses will drive the country’s export growth, a credit rating agency said.
20-Dec-2011 By Nick Taylor
Patheon posted a fourth quarter operating loss as costs related to restructuring offset an uptick in revenues.
Sepha sees growing demand for cost saving testing tech
01-Dec-2011 By Gareth Macdonald
The drug industry's need to improve product quality while reducing production costs is driving global demand for testing technologies according to Sepha.
EMA recalling oncology drugs manufactured by Ben Venue
23-Nov-2011 By Nick Taylor
The EMA is recalling cancer drugs manufactured by CMO Ben Venue Laboratories after inspectors found quality shortcomings.
Shortages to worsen after Ben Venue suspends manufacture
21-Nov-2011 By Nick Taylor
Ben Venue Laboratories has voluntarily suspended manufacture at the Ohio plant linked to drug shortages.
Strategic outsourcing coming to EU packaging, United Drug says
16-Nov-2011 By Nick Taylor
United Drug plans to win strategic packaging relationships in Europe as biopharm companies cut fixed costs through outsourcing.
Trust in drug source may blind wholesalers to counterfeits
15-Nov-2011 By Nick Taylor
Wholesalers’ trust in the quality of products from some countries could decrease vigilance and allow counterfeits to reach pharmacies, research found.
Private equity buys WellSpring and its CMO business
08-Nov-2011 By Nick Taylor
A private equity consortium has bought WellSpring Pharmaceutical and its Canadian contract manufacturing plant.
FDA sends Genentech 483 after finding failings at Avastin plant
08-Nov-2011 By Nick Taylor
The US FDA has sent Genentech a GMP 483 after inspectors found failings in the capping process for Avastin.
07-Nov-2011 By Nick Taylor
Catalent is considering acquisitions as it adds scale, drug delivery technologies and capacity in emerging markets.
West inks pre-filled syringe deal with Vetter
UPDATE
03-Nov-2011 By Natalie Morrison
Injectable drug delivery systems maker West has struck a new joint venture with Vetter to provide source filled Daikyo Crystal Zenith syringes.
Effective outsourcers will have competitive edge in 2020; KPMG
26-Oct-2011 By Nick Taylor
Effectively outsourcing a significant portion of work will give biopharm a competitive advantage in 2020, KPMG said.
Avantor to add tamper-evident seals to raw material containers
20-Oct-2011 By Nick Taylor
Avantor is to offer tamper-evident seals on all its pharma raw material and excipient containers by the end of the year.
CMO Angel & Russian pharma plan drug production JV
18-Oct-2011 By Nick Taylor
Angel Biotechnology is negotiating a joint-venture with a Russian firm that would see it add dedicated production space at a UK site.
Lundbeck cuts back on outsourcing in China with new Shanghai R&D centre
18-Oct-2011 By Natalie Morrison
Danish neurodrug developer H Lundbeck is cutting back its Chinese outsourcing after establishing an R&D centre in Shanghai.
13-Oct-2011 By Nick Taylor
Sproxil and Orange have separately expanded text messaging anti-counterfeiting services in Kenya to tackle fake drugs.
Execs the winners after tax holiday, Senate report says
13-Oct-2011 By Nick Taylor
A Senate report has slammed the ACRO-backed overseas profit tax break for doing more to help execs’ pay packets than US employment.
Vetter opens new US production facility
06-Oct-2011 By Natalie Morrison
Vetter says it will reduce API wastage through its new US production facility for the filling of syringes, cartridges and vials.
Melanoma therapy costs could be slashed thanks to new device, says OncoSec
06-Oct-2011 By Natalie Morrison
The price of melanoma therapy could soon be slashed thanks to a new delivery system developed by US firm OncoSec.
Akorn to enter India in five facility takeover deal
06-Oct-2011 By Nick Taylor
Akorn is to expand its CMO business into India and add sterile injectables capabilities by acquiring five manufacturing plants.
Insulin pens & Brazil buy drive Gerresheimer growth
06-Oct-2011 By Nick Taylor
Gerresheimer posted a jump in sales and upgraded guidance on strong demand for insulin pens and the Vedat acquisition.
Strong R&D spending in China continues despite economic dip
21-Sep-2011 By Nick Taylor
Biopharm is continuing to spend on R&D in China despite the economic dip, and CROs in the region should benefit, an analyst said.
Circassia and NanoPass strike up deal over intradermal device
19-Sep-2011 By Natalie Morrison
Immunotherapy and vaccine specialist Circassia says its new license agreement with NanoPass Technologies will help its range of allergy products to thrive on the market.
Patheon plans facility exits & capability cuts to improve biz
13-Sep-2011 By Nick Taylor
Patheon is exiting semi-solids, clinical packaging and cutting facilities in response to ‘poor historical performance’.
Gerresheimer Regensburg expands China facility
12-Sep-2011 By Natalie Morrison
Gerresheimer Regensburg GmbH has announced plans to increase production of its medical injection moulders four-fold in its China facility over the next 18 months.
Toyobo to ramp up injectables CMO biz
06-Sep-2011
Japanese CMO Toyobo says it will increase capacity for injectable drugs to secure its position as a service provider in the expanding biopharmaceutical sector.
United Drug set to make 150 staff cuts
UPDATE
31-Aug-2011 By Natalie Morrison
United Drug is set to lay off around 150 staff from its Irish supply business.
Alliance awards three-product commercial supply contract to SCM Pharma
UPDATE
25-Aug-2011 By Natalie Morrison
SCM Pharma has inked a commercial supply contract with Alliance for the sterile manufacturing of three of its products.
Needle-free drug delivery is the wave of the future, says Kalorama
23-Aug-2011 By Natalie Morrison
The worldwide market for needle-free drug delivery will double in value over the next five years, according to new market research by Kalorama.
Strategic deals drive Catalent’s $410m move for Aptuit assets
23-Aug-2011 By Nick Taylor
Catalent is to buy clinical trial supply assets from Aptuit for $410m (€285m) as it adds scale to handle the shift to preferred provider relationships.
West to expand US packaging and device R&D centre
16-Aug-2011 By Gareth Macdonald
West Pharmaceutical Services says new R&D centre will focus on elastomer formulations and process development for its packaging and delivery tech businesses.
Hyaluron buy a “money pit” for AMRI, analyst warns
09-Aug-2011 By Nick Taylor
FDA scrutiny of the Burlington, MA sterile plant AMRI bought in 2010 has made the takeover a “money pit”, an analyst said.
EC revises stability testing
08-Aug-2011 By Nick Taylor
The EC has updated stability testing guidance to cover procedures for variations, such as change in batch size, to marketing authorisations.
DSM seeks CMO partner to diversify beyond big pharma
04-Aug-2011 By Nick Taylor
DSM wants to form a CMO joint venture to become less reliant on big pharma clients and revive the flagging business unit.
Vial to prefilled syringe shift on in US ahead of flu season
03-Aug-2011 By Nick Taylor
More-and-more US biopharm companies are moving from vials to prefilled syringes ahead of the upcoming flu season, according to BD.
Bosch sells aseptic filling line to Pharmalucence
01-Aug-2011 By Gareth Macdonald
Robert Bosch Packaging Technology has sold a filling line to US firm Pharmalucence Partners, which is expanding its contract pharmaceutical manufacturing business.
AmerisourceBergen eyes M&A as takeover war chest grows
01-Aug-2011 By Nick Taylor
AmerisourceBergen is looking to buy pharmaceutical packaging and distribution assets using some of the $2bn (€1.4bn) it has accumulated.
West adds pricing surcharge to offset rising commodity costs
01-Aug-2011 By Nick Taylor
West has applied a pricing surcharge to offset rising raw material costs that dragged on margins in the second quarter.
Sherpa opens new packaging plant in CA
20-Jul-2011 By Natalie Morrison
Sherpa has cut the ribbon on a new cGMP biotech clinical trial material packaging facility in San Diego.
12-Jul-2011 By Nick Taylor
Phillips Plastics is to expand into Europe and add primary packaging contract manufacturing capabilities by acquiring Medisize.
Sherpa packaging plant passes Cali FDB inspection
29-Jun-2011 By Gareth Macdonald
Sherpa Clinical Packaging says its new facility has passed an inspection by the California Food and Drug Branch (FDB) of the Department of Public Health.
